Acetic acid disinfection as a potential adjunctive therapy for non‑severe COVID‑19
The main route of transmission of the new coronavirus called COVID-19 (SARS-CoV-2) is through mucosal contact with infected exhaled droplets [1]. Considering thehigher viral load detected in the nose, compared with the lower respiratory tract [2], this may be one of the first anatomical structures exposed to viral contagion as evidenced by the fact that acute anosmia is a relatively common presenting symptom [3, 4]. With the rapid spread of COVID-19, global health-care systems have faced the challenge of treating an overwhelming number of patients for which there is no widespread immunity. As a result, many off-label therapies have been tried but so far with uncertain results.
